Study suggests that persistently activated ATF6α is a tumor driver, a potential stratification marker for immunotherapy response, and a therapeutic target for HCC.

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...

Patients with intermediate stage primary liver cancer who received a vaccine of dendritic cells saw a longer time without tumour progression in response to standard treatment according to a new study ...

Until now, doctors knew hepatic stellate cells mainly as drivers of liver fibrosis. The actual functions of this cell type have hardly been studied to date. Researchers have now determined that ...

New research shows that reducing dietary protein may significantly lower liver cancer risk or slow its progression in people ...

A research team has identified a new mechanism that controls DNA’s ability to replicate—and thereby a cell’s ability to ...